Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,228,506
+$100,603 QoQ
Shares Held
4,882
-5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#2,355
of 4,153 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. ABBV ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,076 | $3,689,446 | |
| 2 | JNJ |
Johnson & Johnson
|
9,737 | $2,472,905 | |
| 3 | AMGN |
Amgen Inc
|
4,049 | $1,466,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,140 | $1,431,490 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
4,882 | $1,228,506 | |
| 6 | NVS |
Novartis AG
|
5,542 | $868,542 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,306 | $536,211 | |
| 8 | GSK |
GSK plc
|
8,000 | $419,360 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,228,506 | 4,882 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,127,903 | 5,186 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,029,118 | 4,504 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,040,540 | 4,494 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $818,955 | 4,412 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $931,944 | 4,448 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $722,350 | 4,065 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $759,310 | 3,845 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $633,423 | 3,693 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $631,704 | 3,469 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $521,629 | 3,366 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $503,524 | 3,378 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $392,468 | 2,913 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $492,612 | 3,091 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $460,750 | 2,851 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $385,987 | 2,876 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $449,677 | 2,936 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $451,638 | 2,786 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $284,475 | 2,101 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $32,361 | 300 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $241,725 | 2,146 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $175,316 | 1,620 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $32,145 | 300 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $26,277 | 300 | Shares | Sole | 2020-10-27 | |
| No filing history on record for this holder in this stock. | ||||||